Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;26(7):356-358.
doi: 10.2459/JCM.0000000000001753. Epub 2025 May 30.

Cardiac scintigraphy for transthyretin amyloidosis: a decade of progress, a future of precision

Affiliations

Cardiac scintigraphy for transthyretin amyloidosis: a decade of progress, a future of precision

Carla Indennidate et al. J Cardiovasc Med (Hagerstown). .
No abstract available

PubMed Disclaimer

References

    1. Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, et al. Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey. JACC CardioOncol 2021; 3:537–546.
    1. Longhi S, Biagini E, Guaraldi P, Carigi S, Dossi MC, Bartolotti M, et al. Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experience. J Cardiovasc Med 2024; 25:682–692.
    1. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133:2404–2412.
    1. Ahluwalia N, Roshankar G, Draycott L, Jimenez-Zepeda V, Fine N, Chan D, et al. Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis. J Nucl Cardiol 2023; 30:2464–2476.
    1. Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al. Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration. JAMA Cardiol 2025; 10:437–445.